Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

23.92USD
22 Jul 2016
Change (% chg)

$0.00 (+0.00%)
Prev Close
$23.92
Open
$23.89
Day's High
$24.01
Day's Low
$23.70
Volume
2,948,953
Avg. Vol
2,968,831
52-wk High
$24.45
52-wk Low
$14.18

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP),... (more)

Overall

Beta: 0.99
Market Cap(Mil.): $32,456.26
Shares Outstanding(Mil.): 1,356.87
Dividend: --
Yield (%): --

Financials

BRIEF-Boston Scientific elects Yoshiaki Fujimori to board

* Boston Scientific elects Yoshiaki Fujimori to board of directors Source text for Eikon: Further company coverage:

13 Jul 2016

BRIEF-Boston Scientific says board increased number of directors from ten to eleven

* Board increased the number of directors comprising the board from ten to eleven - sec filing Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

13 Jul 2016

Jeptoo's lawyer withdraws from CAS hearing

NAIROBI The lawyer representing Kenya's suspended Rita Jeptoo, the Boston and Chicago marathon winner, has withdrawn her services a day before the start of a hearing into the athlete's doping case at the Court of Arbitration for Sport (CAS).

06 Jul 2016

Exclusive: Bayer explores sale of radiology business - sources

NEW YORK/FRANKFURT Bayer AG, the German chemicals and healthcare company trying to acquire Monsanto Co, is exploring a sale of its radiology supplies unit that could be worth more than $3 billion, according to people familiar with the matter.

18 Jun 2016

Exclusive: Bayer explores sale of radiology business - sources

NEW YORK/FRANKFURT Bayer AG , the German chemicals and healthcare company trying to acquire Monsanto Co , is exploring a sale of its radiology supplies unit that could be worth more than $3 billion, according to people familiar with the matter.

17 Jun 2016

BRIEF-Boston Scientific reaffirms 2016 revenue guidance

* Reaffirms FY 2016 revenue guidance provided on April 27, for estimated revenue to be in a range of $8.075 to $8.225 billion

09 Jun 2016

Boston Scientific to restructure in bid to reduce operating expenses

Medical device maker Boston Scientific Corp said on Wednesday it would undergo a global restructuring program that is expected to save the company up to $150 million by 2020.

09 Jun 2016

Boston Scientific to restructure in bid to reduce operating expenses

June 8 Medical device maker Boston Scientific Corp said on Wednesday it would undergo a global restructuring program that is expected to save the company up to $150 million by 2020.

09 Jun 2016

BRIEF-Boston Scientific announces positive long-term outcomes for S-ICD system

* Boston scientific announces positive long-term outcomes for S-ICD system in the EFFORTLESS study

07 May 2016

BRIEF-Boston Scientific announces FDA approval of navigation-enabled ablation catheters

* Announces U.S. FDA approval of navigation-enabled ablation catheters Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

04 May 2016

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $43.17 +0.13
St. Jude Medical, Inc. (STJ.N) $81.70 +0.14
Medtronic PLC (MDT.N) $87.10 -0.84

Earnings vs. Estimates